Beauty sessions may ease trauma of disfiguring cancer surgery
NCT ID NCT06959810
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether specially adapted beauty sessions (onco-esthetics) can help people with head and neck cancer feel better about their changed appearance after treatment. Fifty-five patients will receive three sessions, and researchers will measure how their self-image changes. The goal is to see if this supportive care is feasible and helpful.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Adapted Onco-Esthetics sessions (aesthetic care tailored for cancer patients)
- What this could lead to
- If it works, this could show that onco-esthetics helps patients feel better about their appearance and self-image after disfiguring cancer treatments.
- What could go wrong
- This is a small, early feasibility study with only 55 participants, so results may not apply widely. It measures self-image, not survival or cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 55 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2025
- Expected to finish
-
Sep 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient aged 18 or over * Neoplastic location: oropharynx, oral cavity, hypopharynx, larynx, nasal cavity, salivary glands, cavum, sinus. * Patient due to start oncological treatment (recurrence authorized) * Patient fluent in French. * Affiliation with a social security scheme * Signature of informed consent prior to any specific procedure linked to the study * Treatment with curative intent Exclusion Criteria: * Breast-feeding or pregnant patient * Any associated medical or psychological condition that could compromise the patient's ability to participate in the study * Patient deprived of liberty, under guardianship, or subject to a legal protection measure or unable to express their consent. * Patient unable to undergo trial follow-up for geographical, social or psychopathological reasons.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Aerodigestive tract cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Centre Francois Baclesse
RECRUITINGCaen, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New antibody aims to preserve immune checkpoint while fighting cancer
- Can a radioactive antibody seek out and destroy Hard-to-Treat tumors?
- Can a shorter, targeted radiation course tame throat cancer?
- MRI-Guided tweaks during radiation could spare throat cancer patients from swallowing woes
- Can a new tracer reveal hidden tumors?
- Can a more intense radiation schedule outperform Chemo-Radiation for head and neck cancer?